Symtuza (Darunavir/Cobicistat/Emtricitabine/TAF)
Symtuza offers complete HIV treatment in a single tablet, combining a protease inhibitor with three powerful antiviral boosters.
- Estimated Delivery : Up to 4 business days
- Free Shipping & Returns : On all orders over $200
Symtuza merges darunavir, cobicistat, emtricitabine, and tenofovir alafenamide (TAF) into one convenient tablet.
It’s a full antiretroviral therapy (ART) solution designed for adults and adolescents with HIV-1 infection.
The protease inhibitor (darunavir) blocks viral replication, while cobicistat enhances drug levels for better effectiveness.
Symtuza maintains durable viral suppression and supports immune system recovery.
It’s taken once daily with food and is well-tolerated by most users.
Regular monitoring of liver and kidney function is advised during therapy.
Symtuza is valued for its convenience, efficacy, and long-term safety profile.
Be the first to review “Symtuza (Darunavir/Cobicistat/Emtricitabine/TAF)”
Related products
Triumeq (Dolutegravir/Abacavir/Lamivudine)
Original price was: $3,800.$3,600Current price is: $3,600.Biktarvy (Bictegravir/Emtricitabine/TAF)
Original price was: $4,200.$3,990Current price is: $3,990.Atripla (Efavirenz/Emtricitabine/TDF)
Original price was: $3,200.$3,000Current price is: $3,000.Apretude (Long-Acting Injectable Cabotegravir)
Original price was: $3,700.$3,500Current price is: $3,500.Depo-Provera Contraceptive Injection 150 mg/mL – Single Dose Vial (Rx)
Original price was: $77.$73.15Current price is: $73.15.
Reviews
There are no reviews yet.